— Know what they know.
Not Investment Advice
Also trades as: LLY.DE (XETRA) · $vol 2M · LLY.SW (SIX) · $vol 0M

LLY NYSE

Eli Lilly and Company
1W: +3.7% 1M: +13.1% 3M: +3.2% YTD: -3.4% 1Y: +40.0% 3Y: +142.9% 5Y: +454.8%
$1,065.00
+23.35 (+2.24%)
 
Weekly Expected Move ±6.5%
$874 $940 $1005 $1070 $1136
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Strong Buy · Power 78 · $1.00T mcap · 847M float · 0.364% daily turnover · Short 39% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WIDE EDGE
79.6 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 43.6%  ·  5Y Avg: 32.7%
Cost Advantage
88
Intangibles
84
Switching Cost
53
Network Effect
85
Scale ★
100
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LLY possesses a Wide competitive edge (79.6/100) — durable structural advantages that are difficult for competitors to erode. The primary source of advantage is Efficient Scale. ROIC of 43.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$1230
Low
$1331
Avg Target
$1400
High
Based on 4 analysts since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 33Hold: 9Sell: 3Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$1311.00
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-21 Wolfe Research Initiated $1350 +30.1% $1037.82
2026-05-05 Barclays Emily Field $1350 $1400 +50 +44.6% $967.93
2026-05-01 Morgan Stanley $1327 $1344 +17 +39.8% $961.55
2026-05-01 Cantor Fitzgerald Carter Gould $985 $1230 +245 +26.7% $970.67
2026-04-10 Morgan Stanley $1313 $1327 +14 +41.3% $939.31
2026-03-13 Jefferies Akash Tewari $1015 $1300 +285 +29.9% $1000.78
2026-03-06 Deutsche Bank James Shin $1025 $1285 +260 +29.8% $990.31
2026-03-05 Morgan Stanley Terence Flynn $1290 $1313 +23 +35.0% $972.50
2026-02-24 RBC Capital Trung Huynh Initiated $1250 +19.9% $1042.15
2026-02-19 Barclays $913 $1350 +437 +31.9% $1023.22
2026-02-10 Loop Capital Markets Ilya Zubkov $950 $1200 +250 +17.1% $1025.00
2026-02-05 Scotiabank Initiated $1300 +25.3% $1037.12
2026-02-05 Truist Financial $1182 $1281 +99 +24.7% $1027.51
2026-02-05 Goldman Sachs $1145 $1260 +115 +13.8% $1107.12
2026-02-05 Wells Fargo Mohit Bansal $1000 $1280 +280 +15.6% $1107.12
2026-02-05 BMO Capital Evan Seigerman $1200 $1300 +100 +17.4% $1107.12
2026-01-20 Guggenheim $1163 $1161 -2 +11.8% $1038.40
2026-01-06 UBS Michael Yee $1050 $1250 +200 +17.5% $1064.04
2026-01-05 Leerink Partners David Risinger $715 $1234 +519 +14.2% $1080.36
2025-12-16 Daiwa Narumi Nakagiri $700 $1230 +530 +15.7% $1062.71
2025-12-15 Goldman Sachs $856 $1145 +289 +10.2% $1039.04
2025-12-10 HSBC $700 $1070 +370 +9.0% $981.67
2025-12-04 BMO Capital $1100 $1200 +100 +16.1% $1033.56
2025-12-03 Guggenheim $948 $1163 +215 +11.2% $1046.12
2025-12-02 BMO Capital Evan Seigerman $1010 $1100 +90 +3.9% $1058.48
2025-12-01 National Bank Tim Anderson Initiated $1286 +21.6% $1057.89
2025-11-24 Bernstein $300 $1300 +1000 +22.7% $1059.70
2025-11-24 Morgan Stanley Terence Flynn $1146 $1290 +144 +21.7% $1059.70
2025-11-19 Truist Financial Srikripa Devarakonda Initiated $1182 +12.6% $1049.60
2025-11-10 Loop Capital Markets Ilya Zubkov Initiated $950 -2.0% $969.84
2025-10-31 Cantor Fitzgerald $925 $985 +60 +17.4% $839.16
2025-10-09 Cantor Fitzgerald $825 $925 +100 +9.4% $845.72
2025-10-08 Guggenheim Q3 Mounjaro $401 $948 +547 +12.4% $843.63
2025-09-17 Berenberg Bank $970 $830 -140 +9.2% $760.13
2025-08-17 Daiwa Narumi Nakagiri Initiated $700 -0.2% $701.23
2025-08-13 Cantor Fitzgerald Carter Gould $885 $825 -60 +25.0% $660.26
2025-08-07 Leerink Partners Market Perform $950 $715 -235 +11.6% $640.86
2025-05-02 UBS Trung Huynh $420 $1050 +630 +27.5% $823.62
2025-04-28 HSBC Initiated $700 -20.2% $877.29
2025-03-06 Morgan Stanley $1106 $1146 +40 +25.6% $912.76
2025-01-17 Leerink Partners Andrew Berens $990 $950 -40 +28.4% $740.15
2025-01-16 Berenberg Bank Kerry Holford $1050 $970 -80 +29.9% $746.74
2024-10-31 BMO Capital Evan David Seigerman $1101 $1010 -91 +21.7% $829.74
2024-10-14 Leerink Partners Andrew Berens $410 $990 +580 +6.2% $932.06
2024-09-12 Citigroup Peter Verdult $265 $1060 +795 +13.4% $935.02
2024-08-27 Morgan Stanley Terence Flynn $1083 $1106 +23 +15.5% $957.51
2024-08-14 Berenberg Bank Kerry Holford $1000 $1050 +50 +15.6% $908.05
2024-08-12 Deutsche Bank James Shin $535 $1025 +490 +15.0% $891.68
2024-08-09 Goldman Sachs Chris Shibutani $236 $856 +620 -4.0% $891.68
2024-08-09 Wells Fargo Mohit Bansal $875 $1000 +125 +18.3% $845.31

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LLY receives an overall rating of B. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-18 B+ B
2026-05-06 B B+
2026-05-01 B+ B
2026-04-30 B B+
2026-02-17 C- B
2026-02-05 B+ C-
2026-01-03 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

73 Grade A
Profitability
100
Balance Sheet
56
Earnings Quality
53
Growth
91
Value
41
Momentum
86
Safety
100
Cash Flow
52
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LLY scores highest in Safety (100/100) and lowest in Value (41/100). An overall grade of A places LLY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
7.84
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
-1.76
Possible Manipulator
Ohlson O-Score
-8.45
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 84.9/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 0.81x
Accruals: 5.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LLY scores 7.84, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LLY scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LLY's score of -1.76 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LLY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LLY receives an estimated rating of AA- (score: 84.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LLY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
37.69x
PEG
0.29x
P/S
13.88x
P/B
30.54x
P/FCF
60.68x
P/OCF
40.23x
EV/EBITDA
25.93x
EV/Revenue
11.89x
EV/EBIT
27.26x
EV/FCF
63.27x
Earnings Yield
3.07%
FCF Yield
1.65%
Shareholder Yield
1.32%
Graham Number
$137.12
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 37.7x earnings, LLY commands a growth premium. Graham's intrinsic value formula yields $137.12 per share, 677% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.812
NI / EBT
×
Interest Burden
0.987
EBT / EBIT
×
EBIT Margin
0.436
EBIT / Rev
×
Asset Turnover
0.756
Rev / Assets
×
Equity Multiplier
4.694
Assets / Equity
=
ROE
124.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LLY's ROE of 124.1% is driven by financial leverage (equity multiplier: 4.69x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
67.62%
Fair P/E
143.73x
Intrinsic Value
$4054.99
Price/Value
0.23x
Margin of Safety
77.32%
Premium
-77.32%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LLY's realized 67.6% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $4054.99, LLY appears undervalued with a 77% margin of safety. The adjusted fair P/E of 143.7x compares to the current market P/E of 37.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1065.00
Median 1Y
$1374.07
5th Pctile
$765.52
95th Pctile
$2463.28
Ann. Volatility
33.0%
Analyst Target
$1311.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David A. Ricks
Chair, President, and Chief Executive Officer
$1,700,000 $23,325,000 $36,698,337
Daniel M. Skovronsky,
M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs
$1,490,385 $12,000,000 $17,786,576
Anat Hakim President,
Vice President, General Counsel and Secretary
$1,000,000 $6,000,000 $9,845,518
Lucas Montarce Financial
Vice President and Chief Financial Officer
$1,000,000 $5,000,000 $8,483,315
Jake Van Naarden
Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development
$920,192 $4,500,000 $7,586,097

CEO Pay Ratio

165:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $36,698,337
Avg Employee Cost (SGA/emp): $221,880
Employees: 50,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
50,000
+6.4% YoY
Revenue / Employee
$1,303,580
Rev: $65,179,000,000
Profit / Employee
$412,766
NI: $20,638,300,000
SGA / Employee
$221,880
Avg labor cost proxy
R&D / Employee
$266,750
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 1.5% 1.4% 76.4% 83.8% 77.9% 82.5% 63.6% 57.9% 66.2% 50.8% 48.9% 57.3% 68.5% 78.1% 84.8% 89.0% 1.1% 1.5% 1.0% 1.2% 1.24%
ROA 14.1% 13.9% 11.7% 12.8% 11.9% 12.6% 12.7% 11.6% 13.2% 10.1% 9.2% 10.8% 12.9% 14.7% 14.8% 15.6% 19.3% 25.8% 21.6% 26.4% 26.44%
ROIC 33.5% 36.9% 32.5% 36.4% 37.5% 37.4% 32.2% 28.3% 30.0% 32.3% 26.1% 29.0% 34.3% 37.1% 32.9% 37.1% 42.2% 49.2% 38.6% 43.6% 43.57%
ROCE 21.5% 20.9% 19.2% 20.9% 19.4% 20.4% 22.1% 20.5% 23.7% 20.3% 19.2% 22.1% 26.2% 29.5% 26.7% 28.7% 35.3% 46.5% 34.1% 40.8% 40.81%
Gross Margin 71.0% 78.9% 74.4% 73.5% 78.0% 77.3% 78.8% 76.6% 78.3% 80.4% 80.9% 80.9% 80.8% 81.0% 82.2% 82.5% 84.3% 82.9% 85.1% 81.9% 81.93%
Operating Margin 22.5% 31.5% 30.9% 34.1% 26.9% 29.4% 30.2% 24.6% 28.1% 37.3% 34.1% 31.2% 39.1% 39.8% 42.8% 42.5% 45.8% 47.6% 45.5% 44.7% 44.70%
Net Margin 20.6% 16.4% 21.6% 24.4% 14.7% 20.9% 26.5% 19.3% 21.2% -0.6% 23.4% 25.6% 26.3% 8.5% 32.6% 21.7% 36.4% 31.7% 34.4% 37.4% 37.36%
EBITDA Margin 30.4% 25.3% 29.6% 33.0% 23.4% 29.0% 35.0% 28.7% 31.0% 10.1% 32.4% 35.5% 36.4% 19.7% 42.5% 32.7% 48.2% 44.8% 43.5% 47.3% 47.27%
FCF Margin 18.1% 16.6% 19.0% 19.9% 17.0% 18.3% 16.1% 13.7% 10.9% -0.5% -9.2% -10.6% -9.1% -5.3% 1.1% -2.6% -0.1% 15.2% 13.8% 18.8% 18.80%
OCF Margin 26.5% 24.9% 25.6% 27.6% 25.8% 27.6% 26.3% 24.2% 20.9% 19.1% 12.4% 10.2% 11.6% 14.8% 19.6% 19.0% 20.5% 27.0% 25.8% 28.3% 28.35%
ROE 3Y Avg snapshot only 76.83%
ROE 5Y Avg snapshot only 70.43%
ROA 3Y Avg snapshot only 15.39%
ROIC 3Y Avg snapshot only 30.20%
ROIC Economic snapshot only 39.81%
Cash ROA snapshot only 18.21%
Cash ROIC snapshot only 33.16%
CROIC snapshot only 21.98%
NOPAT Margin snapshot only 37.25%
Pretax Margin snapshot only 43.08%
R&D / Revenue snapshot only 19.53%
SGA / Revenue snapshot only 16.15%
SBC / Revenue snapshot only 0.88%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 32.95 35.54 45.46 42.97 49.92 47.17 54.36 56.16 67.30 100.62 99.16 113.16 110.34 94.93 65.35 66.59 50.64 37.19 46.76 32.60 37.691
P/S Ratio 7.48 7.65 8.96 8.98 9.77 9.73 11.89 11.53 14.82 15.65 15.23 19.33 20.81 19.44 15.36 15.09 13.12 11.52 14.81 11.41 13.882
P/B Ratio 35.45 37.62 28.26 29.33 31.65 31.69 31.87 29.99 41.06 47.13 48.24 64.48 75.21 73.76 48.77 52.11 49.24 48.25 36.37 31.05 30.535
P/FCF 41.35 45.93 47.10 45.22 57.41 53.31 73.79 84.37 136.17 -3043.76 -164.86 -182.82 -229.39 -364.66 1354.90 -582.44 -13921.34 75.91 107.56 60.68 60.680
P/OCF 28.19 30.67 34.95 32.57 37.92 35.22 45.24 47.59 71.00 81.86 122.56 188.98 179.64 131.71 78.49 79.38 63.89 42.63 57.40 40.23 40.235
EV/EBITDA 24.26 26.18 33.17 31.75 36.35 35.12 40.82 41.26 49.40 63.79 63.25 73.99 74.13 65.27 47.43 47.30 37.08 28.26 35.81 25.93 25.934
EV/Revenue 7.97 8.11 9.42 9.42 10.22 10.18 12.38 12.04 15.29 16.09 15.88 19.95 21.39 19.99 16.04 15.71 13.69 12.03 15.35 11.89 11.893
EV/EBIT 29.05 31.57 41.07 39.09 45.29 43.26 49.52 50.27 58.85 78.48 76.98 88.25 86.57 75.32 53.66 53.29 41.03 30.55 37.93 27.26 27.258
EV/FCF 44.02 48.72 49.51 47.44 60.03 55.74 76.84 88.07 140.54 -3128.82 -171.94 -188.69 -235.70 -374.90 1414.06 -606.24 -14523.35 79.26 111.49 63.27 63.274
Earnings Yield 3.0% 2.8% 2.2% 2.3% 2.0% 2.1% 1.8% 1.8% 1.5% 1.0% 1.0% 0.9% 0.9% 1.1% 1.5% 1.5% 2.0% 2.7% 2.1% 3.1% 3.07%
FCF Yield 2.4% 2.2% 2.1% 2.2% 1.7% 1.9% 1.4% 1.2% 0.7% -0.0% -0.6% -0.5% -0.4% -0.3% 0.1% -0.2% -0.0% 1.3% 0.9% 1.6% 1.65%
PEG Ratio snapshot only 0.294
Price/Tangible Book snapshot only 58.375
EV/OCF snapshot only 41.955
EV/Gross Profit snapshot only 14.242
Acquirers Multiple snapshot only 25.930
Shareholder Yield snapshot only 1.32%
Graham Number snapshot only $137.12
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.40 1.40 1.23 1.23 1.23 1.23 1.05 1.05 1.05 1.05 0.94 0.94 0.94 0.94 1.15 1.15 1.15 1.15 1.58 1.58 1.579
Quick Ratio 1.08 1.08 0.97 0.97 0.97 0.97 0.80 0.80 0.80 0.80 0.73 0.73 0.73 0.73 0.89 0.89 0.89 0.89 1.19 1.19 1.189
Debt/Equity 2.94 2.94 1.88 1.88 1.88 1.88 1.52 1.52 1.52 1.52 2.34 2.34 2.34 2.34 2.37 2.37 2.37 2.37 1.60 1.60 1.602
Net Debt/Equity 2.29 2.29 1.45 1.45 1.45 1.45 1.32 1.32 1.32 1.32 2.07 2.07 2.07 2.07 2.13 2.13 2.13 2.13 1.33 1.33 1.328
Debt/Assets 0.36 0.36 0.35 0.35 0.35 0.35 0.33 0.33 0.33 0.33 0.39 0.39 0.39 0.39 0.43 0.43 0.43 0.43 0.38 0.38 0.378
Debt/EBITDA 1.89 1.93 2.10 1.94 2.07 1.99 1.88 2.01 1.78 2.01 2.94 2.60 2.25 2.02 2.21 2.07 1.71 1.33 1.52 1.28 1.283
Net Debt/EBITDA 1.47 1.50 1.61 1.49 1.59 1.53 1.62 1.74 1.54 1.73 2.60 2.30 1.99 1.78 1.98 1.86 1.54 1.19 1.26 1.06 1.063
Interest Coverage 20.74 20.52 19.12 20.99 19.82 20.91 21.53 18.98 19.74 15.23 14.49 14.44 15.36 15.62 17.24 17.10 19.52 26.09 33.16 35.68 35.676
Equity Multiplier 8.27 8.27 5.44 5.44 5.44 5.44 4.65 4.65 4.65 4.65 5.94 5.94 5.94 5.94 5.55 5.55 5.55 5.55 4.24 4.24 4.239
Cash Ratio snapshot only 0.206
Debt Service Coverage snapshot only 37.498
Cash to Debt snapshot only 0.171
FCF to Debt snapshot only 0.320
Defensive Interval snapshot only 368.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.62 0.65 0.59 0.61 0.61 0.61 0.58 0.56 0.60 0.65 0.60 0.63 0.69 0.72 0.63 0.69 0.75 0.83 0.68 0.76 0.756
Inventory Turnover 1.92 1.95 1.86 1.91 1.78 1.81 1.62 1.51 1.60 1.67 1.40 1.41 1.49 1.55 1.26 1.34 1.38 1.51 0.99 1.12 1.117
Receivables Turnover 5.13 5.33 4.51 4.67 4.63 4.66 4.21 4.08 4.35 4.73 4.27 4.50 4.87 5.11 4.48 4.88 5.30 5.91 4.53 5.02 5.023
Payables Turnover 4.57 4.64 4.46 4.58 4.26 4.35 3.68 3.43 3.64 3.80 3.13 3.15 3.31 3.45 2.89 3.08 3.17 3.46 2.45 2.77 2.769
DSO 71 69 81 78 79 78 87 89 84 77 85 81 75 71 81 75 69 62 81 73 72.7 days
DIO 190 187 196 191 206 201 226 242 228 219 260 258 246 236 290 272 264 242 369 327 326.7 days
DPO 80 79 82 80 86 84 99 106 100 96 117 116 110 106 126 119 115 105 149 132 131.8 days
Cash Conversion Cycle 182 177 195 190 199 196 213 225 212 200 229 223 210 201 245 228 218 198 300 268 267.5 days
Fixed Asset Turnover snapshot only 2.928
Operating Cycle snapshot only 399.4 days
Cash Velocity snapshot only 9.941
Capital Intensity snapshot only 1.557
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 16.5% 19.6% 15.4% 15.1% 8.8% 5.3% 0.8% -5.6% 1.5% 9.7% 19.6% 29.8% 31.9% 27.4% 32.0% 36.4% 36.8% 45.4% 44.7% 47.4% 47.44%
Net Income 8.1% 7.2% -9.9% 0.6% -6.2% 1.0% 11.9% -7.2% 14.2% -17.3% -16.1% 7.9% 13.0% 67.8% 1.0% 80.9% 88.0% 1.2% 94.9% 1.3% 1.28%
EPS 13.5% 7.2% -9.6% 1.5% -5.5% 6.9% 12.3% -7.1% 8.6% -21.3% -11.8% 13.4% 18.6% 76.0% 1.0% 81.6% 88.9% 1.2% 96.0% 1.3% 1.29%
FCF -1.3% -9.8% 20.2% 4.7% 2.3% 15.5% -14.6% -35.0% -35.1% -1.0% -1.7% -2.0% -2.1% -12.2% 1.2% 66.6% 98.6% 5.1% 16.6% 11.7% 11.69%
EBITDA 9.6% 6.4% -9.8% -0.9% -6.9% -1.5% 7.7% -7.1% 11.8% -4.5% -1.1% 19.9% 22.9% 54.7% 77.7% 68.0% 75.1% 1.0% 83.5% 1.0% 1.04%
Op. Income 11.9% 23.2% 10.8% 23.6% 26.0% 14.5% 9.9% -12.3% -7.9% 9.9% 24.7% 53.3% 67.4% 52.0% 62.2% 70.9% 64.8% 79.4% 69.7% 64.3% 64.25%
OCF Growth snapshot only 1.20%
Asset Growth snapshot only 42.89%
Equity Growth snapshot only 86.97%
Debt Growth snapshot only 26.33%
Shares Change snapshot only -0.52%
Dividend Growth snapshot only 14.99%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 6.1% 8.0% 8.3% 9.4% 9.0% 8.9% 8.5% 6.2% 8.7% 11.4% 11.6% 12.1% 13.4% 13.8% 16.7% 18.7% 22.4% 26.7% 31.7% 37.7% 37.67%
Revenue 5Y 5.3% 5.9% 5.9% 6.3% 5.7% 5.4% 4.5% 4.1% 5.7% 7.8% 8.9% 9.9% 11.6% 12.5% 15.1% 16.2% 18.3% 20.7% 21.6% 23.2% 23.17%
EPS 3Y 1.4% 23.2% 0.5% -8.1% -6.9% -8.9% 1.2% 5.2% -3.4% -3.6% 2.3% 6.8% 14.0% 26.1% 24.1% 34.5% 45.3% 51.8% 67.6% 67.62%
EPS 5Y 24.4% 23.0% 18.7% 26.6% 23.2% 27.0% 41.1% 64.3% 13.1% 1.3% 0.0% 2.2% 6.2% 16.4% 21.2% 28.6% 28.8% 34.8% 34.75%
Net Income 3Y 1.4% 20.0% -0.7% -10.1% -8.8% -9.1% 0.9% 5.0% -3.6% -5.4% 0.3% 6.5% 11.9% 23.8% 21.9% 34.3% 45.1% 49.0% 64.4% 64.41%
Net Income 5Y 19.7% 19.6% 15.3% 22.9% 18.4% 22.1% 38.3% 61.8% 10.1% -0.4% -1.3% 1.0% 4.9% 15.0% 19.7% 27.0% 27.2% 32.9% 32.92%
EBITDA 3Y 28.2% 20.2% 13.1% 21.2% 9.8% 11.2% 7.9% 1.3% 4.5% 0.0% -1.3% 3.3% 8.6% 13.3% 23.7% 23.2% 34.0% 44.0% 47.8% 60.1% 60.05%
EBITDA 5Y 13.6% 13.3% 9.7% 13.8% 10.8% 13.4% 16.8% 8.6% 17.0% 10.3% 9.0% 14.7% 12.7% 15.2% 17.2% 15.9% 19.7% 25.6% 25.7% 30.4% 30.42%
Gross Profit 3Y 5.8% 7.3% 7.0% 8.0% 8.1% 7.9% 7.6% 5.6% 8.3% 11.6% 12.4% 14.2% 16.6% 16.7% 20.4% 22.4% 25.8% 30.7% 35.6% 41.0% 41.03%
Gross Profit 5Y 5.5% 6.4% 6.2% 6.5% 6.4% 6.0% 5.5% 5.2% 6.5% 8.4% 9.5% 10.7% 12.5% 13.4% 15.8% 17.0% 19.5% 22.1% 23.4% 25.6% 25.55%
Op. Income 3Y 12.3% 13.6% 8.7% 13.6% 15.1% 14.2% 13.0% 5.9% 9.1% 15.8% 15.0% 18.4% 24.8% 24.1% 30.5% 31.9% 36.4% 44.2% 50.8% 62.6% 62.62%
Op. Income 5Y 14.9% 16.9% 15.3% 16.2% 15.0% 13.7% 14.4% 10.3% 10.5% 13.1% 12.0% 14.6% 18.6% 20.0% 23.9% 25.5% 29.1% 33.4% 33.1% 36.1% 36.06%
FCF 3Y 23.9% 16.4% 29.1% 38.0% 14.2% 26.0% 9.7% 0.8% -13.2% -54.4% 19.1% 24.9% 53.1% 53.08%
FCF 5Y 21.7% 13.4% 6.9% 5.7% 1.1% 2.6% 1.4% -2.6% 4.8% -31.9% 12.0% 14.9% 19.5% 19.53%
OCF 3Y 8.3% 5.9% 9.5% 14.4% 15.0% 23.2% 15.8% 11.0% -1.0% -2.7% -13.3% -22.2% -14.0% -4.5% 6.7% 4.8% 13.4% 25.7% 30.9% 45.1% 45.05%
OCF 5Y 18.1% 13.7% 7.9% 7.9% 5.4% 6.2% 6.0% 3.3% 2.0% 1.1% -5.2% -7.4% -1.8% 6.9% 12.8% 13.7% 11.5% 19.3% 20.9% 21.3% 21.25%
Assets 3Y 1.2% 1.2% 3.6% 3.6% 3.6% 3.6% 8.0% 8.0% 8.0% 8.0% 11.1% 11.1% 11.1% 11.1% 17.3% 17.3% 17.3% 17.3% 31.5% 31.5% 31.48%
Assets 5Y 5.6% 5.6% 4.7% 4.7% 4.7% 4.7% 1.9% 1.9% 1.9% 1.9% 7.8% 7.8% 7.8% 7.8% 14.9% 14.9% 14.9% 14.9% 19.3% 19.3% 19.25%
Equity 3Y -21.3% -21.3% -3.0% -3.0% -3.0% -3.0% 59.9% 59.9% 59.9% 59.9% 24.1% 24.1% 24.1% 24.1% 16.5% 16.5% 16.5% 16.5% 35.6% 35.6% 35.57%
Book Value 3Y -18.0% -19.5% -0.3% -1.8% -0.8% -1.0% 60.3% 60.3% 60.3% 60.3% 26.4% 26.6% 24.3% 26.4% 18.6% 18.6% 16.6% 16.7% 38.1% 38.2% 38.21%
Dividend 3Y 9.0% 7.1% 7.6% 5.9% 7.1% 6.8% 4.9% 5.0% 5.0% 5.0% 6.8% 6.9% 5.0% 6.8% 6.7% 6.7% 4.9% 4.9% 6.8% 6.8% 6.81%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.77 0.74 0.76 0.79 0.78 0.75 0.76 0.76 0.88 0.92 0.90 0.81 0.84 0.88 0.85 0.78 0.82 0.82 0.81 0.79 0.789
Earnings Stability 0.41 0.44 0.47 0.63 0.36 0.41 0.44 0.38 0.28 0.14 0.01 0.00 0.00 0.00 0.06 0.48 0.60 0.54 0.59 0.59 0.593
Margin Stability 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.96 0.97 0.96 0.96 0.96 0.962
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.00 1.00 0.00 1.00 0.50 0.00 0.50 0.00 0.00 0.50 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 0 0
Earnings Persistence 0.97 0.97 0.96 1.00 0.98 1.00 0.95 0.97 0.94 0.93 0.94 0.97 0.95 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.92 0.93 0.90 0.99 0.94 0.99 0.89 0.93 0.87 0.81 0.83 0.92 0.88 0.49 0.32 0.42 0.39 0.25 0.36 0.22 0.221
ROE Trend -0.40 -0.41 -1.52 -0.92 -0.98 -0.93 -0.27 -0.35 -0.24 -0.40 -0.12 -0.04 0.06 0.21 0.21 0.23 0.33 0.67 0.16 0.28 0.276
Gross Margin Trend -0.04 -0.03 -0.04 -0.03 -0.00 -0.01 0.01 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.04 0.03 0.026
FCF Margin Trend 0.00 -0.00 0.02 0.01 -0.03 -0.01 -0.03 -0.07 -0.07 -0.18 -0.27 -0.27 -0.23 -0.14 -0.02 -0.04 -0.01 0.18 0.18 0.25 0.254
Sustainable Growth Rate 77.3% 72.5% 34.1% 40.1% 32.5% 35.7% 27.6% 20.6% 27.5% 10.7% 10.9% 17.9% 27.7% 35.8% 47.3% 50.1% 70.2% 1.1% 74.9% 96.7% 96.69%
Internal Growth Rate 8.0% 7.5% 5.5% 6.5% 5.2% 5.8% 5.8% 4.3% 5.8% 2.2% 2.1% 3.5% 5.5% 7.3% 9.0% 9.6% 14.0% 22.7% 19.0% 25.9% 25.94%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.17 1.16 1.30 1.32 1.32 1.34 1.20 1.18 0.95 1.23 0.81 0.60 0.61 0.72 0.83 0.84 0.79 0.87 0.81 0.81 0.810
FCF/OCF 0.68 0.67 0.74 0.72 0.66 0.66 0.61 0.56 0.52 -0.03 -0.74 -1.03 -0.78 -0.36 0.06 -0.14 -0.00 0.56 0.53 0.66 0.663
FCF/Net Income snapshot only 0.537
OCF/EBITDA snapshot only 0.618
CapEx/Revenue 8.4% 8.3% 6.6% 7.7% 8.8% 9.4% 10.2% 10.6% 10.0% 19.6% 21.7% 20.8% 20.7% 20.1% 18.4% 21.6% 20.6% 11.9% 12.0% 9.6% 9.55%
CapEx/Depreciation snapshot only 4.287
Accruals Ratio -0.02 -0.02 -0.04 -0.04 -0.04 -0.04 -0.03 -0.02 0.01 -0.02 0.02 0.04 0.05 0.04 0.02 0.03 0.04 0.03 0.04 0.05 0.050
Sloan Accruals snapshot only 0.151
Cash Flow Adequacy snapshot only 1.640
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 1.4% 1.4% 1.2% 1.2% 1.2% 1.2% 1.0% 1.1% 0.9% 0.8% 0.8% 0.6% 0.5% 0.6% 0.7% 0.7% 0.7% 0.8% 0.6% 0.7% 0.61%
Dividend/Share $3.17 $3.12 $3.24 $3.36 $3.67 $3.79 $3.72 $3.86 $4.00 $4.15 $4.50 $4.67 $4.84 $5.01 $5.18 $5.39 $5.59 $5.79 $6.00 $6.23 $6.46
Payout Ratio 47.5% 50.0% 55.3% 52.2% 58.2% 56.8% 56.6% 64.5% 58.5% 78.9% 77.7% 68.8% 59.6% 54.1% 44.2% 43.7% 36.5% 28.3% 26.1% 22.1% 22.10%
FCF Payout Ratio 59.6% 64.6% 57.3% 54.9% 66.9% 64.1% 76.9% 96.9% 1.2% 9.2% 57.7% 60.0% 41.1% 41.13%
Total Payout Ratio 55.8% 58.3% 77.7% 97.0% 97.7% 94.1% 80.6% 77.7% 70.1% 93.9% 92.0% 68.8% 59.6% 59.5% 67.8% 77.1% 68.3% 53.6% 46.0% 42.9% 42.93%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.157
Buyback Yield 0.2% 0.2% 0.5% 1.0% 0.8% 0.8% 0.4% 0.2% 0.2% 0.1% 0.1% 0.0% 0.0% 0.1% 0.4% 0.5% 0.6% 0.7% 0.4% 0.6% 0.64%
Net Buyback Yield 0.2% 0.2% 0.5% 1.0% 0.8% 0.8% 0.4% 0.2% 0.2% 0.1% 0.1% 0.0% 0.0% 0.1% 0.4% 0.5% 0.6% 0.7% 0.4% 0.6% 0.64%
Total Shareholder Return 1.7% 1.6% 1.7% 2.3% 2.0% 2.0% 1.5% 1.4% 1.0% 0.9% 0.9% 0.6% 0.5% 0.6% 1.0% 1.2% 1.3% 1.4% 1.0% 1.3% 1.32%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.87 0.88 0.91 0.91 0.91 0.92 0.92 0.91 0.89 0.81 0.80 0.81 0.82 0.82 0.84 0.82 0.82 0.82 0.80 0.81 0.812
Interest Burden (EBT/EBIT) 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.93 0.93 0.93 0.93 0.94 0.94 0.94 0.95 0.96 0.98 0.99 0.987
EBIT Margin 0.27 0.26 0.23 0.24 0.23 0.24 0.25 0.24 0.26 0.20 0.21 0.23 0.25 0.27 0.30 0.29 0.33 0.39 0.40 0.44 0.436
Asset Turnover 0.62 0.65 0.59 0.61 0.61 0.61 0.58 0.56 0.60 0.65 0.60 0.63 0.69 0.72 0.63 0.69 0.75 0.83 0.68 0.76 0.756
Equity Multiplier 10.42 10.42 6.53 6.53 6.53 6.53 5.01 5.01 5.01 5.01 5.30 5.30 5.30 5.30 5.72 5.72 5.72 5.72 4.69 4.69 4.694
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $6.67 $6.24 $5.85 $6.45 $6.30 $6.68 $6.57 $5.99 $6.84 $5.25 $5.80 $6.79 $8.12 $9.25 $11.73 $12.33 $15.34 $20.49 $22.98 $28.21 $28.21
Book Value/Share $6.20 $5.90 $9.42 $9.45 $9.94 $9.93 $11.21 $11.22 $11.22 $11.22 $11.92 $11.92 $11.91 $11.90 $15.71 $15.76 $15.77 $15.79 $29.55 $29.62 $34.88
Tangible Book/Share $-6.12 $-5.83 $-2.73 $-2.74 $-2.88 $-2.88 $-0.66 $-0.66 $-0.66 $-0.66 $-1.19 $-1.19 $-1.19 $-1.19 $2.50 $2.50 $2.51 $2.51 $15.72 $15.76 $15.76
Revenue/Share $29.36 $29.02 $29.69 $30.85 $32.20 $32.35 $30.04 $29.17 $31.09 $33.79 $37.75 $39.76 $43.05 $45.15 $49.87 $54.41 $59.19 $66.11 $72.58 $80.64 $80.77
FCF/Share $5.31 $4.83 $5.65 $6.13 $5.48 $5.91 $4.84 $3.99 $3.38 $-0.17 $-3.49 $-4.20 $-3.91 $-2.41 $0.57 $-1.41 $-0.06 $10.04 $9.99 $15.16 $15.18
OCF/Share $7.79 $7.23 $7.61 $8.51 $8.30 $8.94 $7.90 $7.07 $6.49 $6.46 $4.69 $4.07 $4.99 $6.67 $9.76 $10.35 $12.16 $17.87 $18.72 $22.86 $22.90
Cash/Share $4.04 $3.85 $4.10 $4.11 $4.33 $4.32 $2.33 $2.33 $2.33 $2.33 $3.24 $3.24 $3.24 $3.24 $3.79 $3.80 $3.80 $3.81 $8.09 $8.11 $5.90
EBITDA/Share $9.64 $8.99 $8.43 $9.15 $9.05 $9.37 $9.11 $8.51 $9.62 $8.52 $9.48 $10.72 $12.42 $13.83 $16.86 $18.07 $21.85 $28.14 $31.11 $36.98 $36.98
Debt/Share $18.23 $17.35 $17.71 $17.76 $18.70 $18.68 $17.09 $17.11 $17.11 $17.11 $27.90 $27.91 $27.90 $27.87 $37.25 $37.36 $37.39 $37.43 $47.33 $47.44 $47.44
Net Debt/Share $14.18 $13.50 $13.61 $13.65 $14.37 $14.36 $14.76 $14.78 $14.78 $14.78 $24.67 $24.67 $24.66 $24.64 $33.46 $33.56 $33.59 $33.62 $39.24 $39.33 $39.33
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 7.842
Altman Z-Prime snapshot only 13.850
Piotroski F-Score 7 7 6 7 7 6 8 6 6 6 6 6 6 7 8 8 8 8 8 7 7
Beneish M-Score -2.25 -2.30 -2.45 -2.48 -2.52 -2.49 -2.59 -2.57 -2.35 -2.46 -2.08 -1.99 -1.92 -1.99 -2.11 -2.11 -2.10 -2.04 -1.89 -1.76 -1.759
Ohlson O-Score snapshot only -8.452
ROIC (Greenblatt) snapshot only 69.93%
Net-Net WC snapshot only $-33.83
EVA snapshot only $20733365700.85
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 78.24 77.10 77.94 81.10 75.05 83.66 78.39 76.84 75.26 71.30 65.37 64.30 65.43 65.54 70.11 68.76 70.93 76.95 82.25 84.92 84.924
Credit Grade snapshot only 4
Credit Trend snapshot only 16.164
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 66
Sector Credit Rank snapshot only 83

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms